E-ISSN: 1308-5263
Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center [Turk J Hematol]
Turk J Hematol. 2023; 40(3): 213-215 | DOI: 10.4274/tjh.galenos.2023.2023.0089  

Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center

Hakan Göker, Olgu Erkin Çınar, Haluk Demiroğlu, Ümit Yavuz Malkan, Elifcan Aladağ Karakulak, Yahya Büyükaşık
Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye

Keywords: Venetoclax, Azacitidine, Relapsed acute myeloid leukemia, Hematopoietic stem cell transplantation


Hematopoetik Kök Hücre Nakli Sonrası Nüks Eden Akut Myeloid Lösemide Venetoklaks ve Azasitidin Tedavisi: Üçüncü Basamak Kohortunda Gerçek Yaşam Deneyimi

Hakan Göker, Olgu Erkin Çınar, Haluk Demiroğlu, Ümit Yavuz Malkan, Elifcan Aladağ Karakulak, Yahya Büyükaşık
Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye

Anahtar Kelimeler: Venetoklaks, Azasitidin, Nüks akut myeloid lösemi, Hematopoetik kök hücre nakli


Hakan Göker, Olgu Erkin Çınar, Haluk Demiroğlu, Ümit Yavuz Malkan, Elifcan Aladağ Karakulak, Yahya Büyükaşık. Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center. Turk J Hematol. 2023; 40(3): 213-215

Corresponding Author: Hakan Göker, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar